ABOUT CONTACT US LOGIN

Morisky Widget MMAS-8 medication adherence and medication reconciliation software can prevent premature morbidity and mortality rates, medical complications, hospital re-admissions and emergency room visits for patients with chronic and infectious disease, mental health and opioid use disorders.

Whereas the MMAS-8 paper questionnaire had only 73% “true positive” sensitivity, which means that “27 out of 100” patients are possibly misdiagnosed for their correct level of medication adherence, the Morisky Widget MMAS-8 condition and medication specific assessments offers “true positive” sensitivity of 93%.misdiagnosing just “7 out of 100” patients.

Whereas the MMAS-8 paper questionnaire was a measurement of medication adherence, the Morisky Widget MMAS-8 software is a diagnostic assessment of medication taking behavior that identifies why the patient is not taking their medication.

Whereas the MMAS-8 paper questionnaire was usually administered as a survey for a non-clinical research study, the Morisky Widget MMAS-8 software is administered, scored, and reported for clinical applications such as Medication Reconciliation that are reimbursable under CMS Chronic Care Management CPT 99490

Whereas the MMAS-8 paper questionnaire was limited to measuring adherence for a single medication taken once a day, the Morisky Widget MMAS-8 software can be easily modified for different types of medication administration, frequency, dosage, and polypharmacy issues without any changes in the construct validity of the Morisky Widget MMAS-8.

The Morisky Widget MMAS-8 hyperlipidemia assessment below for Repatha, an elevated cholesterol medication is taken every two weeks, The MMAS-8 paper questionnaire #5 has been changed from “Did you take your medicine yesterday” to “Did you take Repatha the last time you were supposed to take it?”

The Morisky Widget condition and medication specific assessment shown above 1) measures the level of adherence for Repatha an elevated cholesterol medication, 2) measures the severity of Major Depressive Disorder, a determinant of non-adherence 3) identifies why the patient is not taking their Repatha medication, 4) determines the risk between non-adherence to Repatha with current LDL & BP measures of disease control.

The Morisky Widget assessment results targets and tailors Interventions to improve medication adherence. These interventions can change medication taking behaviors for the highest risk, lowest adherent patients, especially those with unintentional non-adherence and cognitive impairment.

24x7x365 Home Monitoring Video Direct Observation Therapy

24x7x365 Home Monitoring Hypertension Blood Pressure

24x7x365 Home Monitoring EKG Recurrent Afib

24x7x365 Home Monitoring Glucose Levels

24x7x365 Home Monitoring Mabu Robot

Use of the © Morisky Widget Software is protected by US copyright laws. Permission for use is required. A Morisky Widget software license agreement is available from MMAS Research LLC. Click here to contact us.